As countries celebrate World Alzheimer’s Month and World Alzheimer’s Day in September, the international campaign to raise awareness and challenge the stigma that surrounds dementia continues to intensify.
Mr. Vonz Santos, the owner of biotech company, Amylex, introduces an innovation in the search for the cure to Alzheimer’s disease. He explains the process of intervening in the pathological process of beta Amyloids in the body to prevent them from becoming deadly.
Rogelio Santos, Jr., CEO of Aevolve, a new platform dedicated to supporting innovative medical research, recently commented on the disturbing gap that exists between the millions of people who have been diagnosed with a rare disease and the life-saving medical treatment they are currently lacking. “Shockingly, 95% of all rare diseases today have absolutely no treatment.
Aevolve, a Zurich-based healthtech company, has announced the filing of the first crypto token to be offered in a tracker certificate for subscription through the SIX Swiss Exchange.
